IN2015DN03125A - - Google Patents

Download PDF

Info

Publication number
IN2015DN03125A
IN2015DN03125A IN3125DEN2015A IN2015DN03125A IN 2015DN03125 A IN2015DN03125 A IN 2015DN03125A IN 3125DEN2015 A IN3125DEN2015 A IN 3125DEN2015A IN 2015DN03125 A IN2015DN03125 A IN 2015DN03125A
Authority
IN
India
Prior art keywords
cmi
present
invention further
measuring
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Morten Ruhwald
Pemille Ravn
Jesper Eugen-Olsen
Original Assignee
Hvidovre Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hvidovre Hospital filed Critical Hvidovre Hospital
Publication of IN2015DN03125A publication Critical patent/IN2015DN03125A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32—Mycobacterium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/02—Hepadnaviridae, e.g. hepatitis B virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Jellies, Jams, And Syrups (AREA)
IN3125DEN2015 2006-09-05 2007-09-05 IN2015DN03125A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200601145 2006-09-05
DKPA200700262 2007-02-20
PCT/DK2007/000399 WO2008028489A2 (en) 2006-09-05 2007-09-05 Ip-i0 based immunological monitoring

Publications (1)

Publication Number Publication Date
IN2015DN03125A true IN2015DN03125A (de) 2015-10-02

Family

ID=38716188

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3125DEN2015 IN2015DN03125A (de) 2006-09-05 2007-09-05

Country Status (17)

Country Link
US (2) US8026076B2 (de)
EP (4) EP2128612B1 (de)
JP (1) JP5805368B2 (de)
KR (1) KR101248491B1 (de)
CN (1) CN101523217B (de)
AT (1) ATE504000T1 (de)
AU (1) AU2007294293B2 (de)
BR (1) BRPI0714744B8 (de)
CA (1) CA2662429C (de)
DE (1) DE602007013620D1 (de)
DK (2) DK2128612T3 (de)
EA (1) EA020412B1 (de)
IN (1) IN2015DN03125A (de)
PL (1) PL2128612T3 (de)
PT (1) PT2128612E (de)
WO (1) WO2008028489A2 (de)
ZA (1) ZA200902297B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0722105D0 (en) 2007-11-10 2007-12-19 Sec Dep For Environment Food A Antigens
KR20110036590A (ko) * 2008-06-25 2011-04-07 베일러 리서치 인스티튜트 결핵균 감염의 혈액 전사 시그너처
EP3431987A1 (de) * 2008-07-25 2019-01-23 Cellestis Limited Diagnoseverfahren
BRPI0922798B1 (pt) * 2008-12-15 2022-12-13 Antrum Biotech (Proprietary) Limited Dispositivo e kit para diagnosticar tuberculose
GB0906215D0 (en) 2009-04-09 2009-05-20 Lalvani Ajit Diagnostic test
DK2365332T3 (da) * 2010-03-10 2013-08-26 Pasteur Institut HMGB1- og anti-HMGB1-antistoffer i HIV-inficerede patienter, især med neurologiske lidelser
US20130078657A1 (en) * 2010-05-04 2013-03-28 Hvidovre Hospital Hyperthermia augmented in-vitro immune recognition
EP2649455A1 (de) * 2010-12-09 2013-10-16 Hvidovre Hospital Verfahren zum erzeugen, speichern, transportieren, eluieren und erkennen von klinisch relevanteninformationen in plasma mittels filterpapier
WO2012139591A1 (en) 2011-04-13 2012-10-18 Hvidovre Hospital Monitoring liver fibrosis in a hepatitis c infected patient
EA201391582A1 (ru) * 2011-04-29 2014-03-31 Бристол-Майерс Сквибб Компани Режимы повышения дозы антител против ip-10
CN103122033B (zh) * 2011-11-21 2015-08-19 厦门大学 一种嵌合重组抗原及其用途
US20140342936A1 (en) * 2011-12-15 2014-11-20 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and kits for diagnosing latent tuberculosis infection
AU2013217935B2 (en) 2012-02-09 2018-05-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
WO2013168876A1 (ko) 2012-05-11 2013-11-14 가톨릭대학교 산학협력단 이식 후 면역 상태를 모니터링 하는 키트 및 이를 이용한 면역 상태의 모니터링 방법
JP6102438B2 (ja) 2012-05-30 2017-03-29 三菱化学株式会社 軸受部材、端部部材、感光体ドラムユニット、プロセスカートリッジ、及び軸受部材の製造方法
JP6020237B2 (ja) 2013-02-15 2016-11-02 三菱化学株式会社 軸受部材、端部部材、感光体ドラムユニット、及び軸受部材の製造方法
CA2923822A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
KR101542510B1 (ko) 2014-01-15 2015-08-18 대한민국 초기 hiv-1 감염자에서 급속한 aids 질환 진행을 예측하기 위한 ip-10의 용도
AP2016009427A0 (en) * 2014-02-26 2016-08-31 Univ Stellenbosch Method for diagnosing tuberculosis
WO2015164747A1 (en) * 2014-04-24 2015-10-29 Immusant, Inc. Methods for diagnosing celiac disease using circulating cytokines/chemokines
KR101590324B1 (ko) * 2014-04-24 2016-02-01 연세대학교 산학협력단 향상된 결핵 진단 방법
RU2730836C2 (ru) 2014-08-14 2020-08-26 Мемед Диагностикс Лтд. Вычислительный анализ биологических данных с применением многообразия и гиперплоскости
KR101748296B1 (ko) 2014-09-04 2017-06-19 연세대학교 산학협력단 마이코박테리움 압세수스 복합체 감염 폐질환 진단용 바이오마커 조성물
WO2016054038A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease
HK1244821A1 (zh) 2014-11-21 2018-08-17 Immusant Inc. 用於治疗和诊断1型糖尿病中使用的肽
EP3230740B1 (de) 2014-12-11 2025-05-21 Memed Diagnostics Ltd. Markerkombinationen zur diagnose von infektionen und verfahren zur verwendung davon
CN104897893A (zh) * 2015-06-10 2015-09-09 复旦大学附属华山医院 一种基于结核特异性il-31检测的诊断结核分枝杆菌感染的试剂盒
CA3015046A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
WO2017149547A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
WO2018011796A1 (en) * 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
WO2018011795A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
WO2018060999A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of risk assessment and disease classification
CN108548917B (zh) * 2018-03-01 2021-07-06 广州市雷德生物科技有限公司 一种记忆性免疫细胞的检测体系及其应用
US20220056528A1 (en) 2018-12-20 2022-02-24 Mikrogen Gmbh Method of detecting infection with pathogens causing tuberculosis
WO2021255237A1 (en) 2020-06-19 2021-12-23 Mikrogen Gmbh Method of detecting infection with pathogens causing tuberculosis
WO2022169842A1 (en) * 2021-02-02 2022-08-11 Revelation Biosciences, Inc. Rapid detection kits and methods for diagnosing infections of the respiratory tract
WO2022240887A1 (en) * 2021-05-10 2022-11-17 Icahn School Of Medicine At Mount Sinai Methods for detecting and staging cellular viral immune responses

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777130A (en) * 1984-12-05 1988-10-11 Andra Biologicals Isolation of mycobacterial a 60 antigen for diagnostic purposes
CA2378763A1 (en) * 1999-07-13 2001-01-18 Statens Serum Institut Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family
WO2002033421A1 (en) * 2000-10-18 2002-04-25 The Government Of The United States Of America, As Represented By The Secretary Of The Navy A novel assay for detecting immune responses involving antigen specific cytokine and/or antigen specific cytokine secreting t-cells
US20040038201A1 (en) 2002-01-22 2004-02-26 Whitehead Institute For Biomedical Research Diagnostic and therapeutic applications for biomarkers of infection
EP2157101B1 (de) * 2002-01-31 2014-09-24 Andromeda Bio Tech Ltd. HSP-Peptide und Analoga zur Modulation von Immunantworten mittels antigenpräsentierenden Zellen
AU2002952548A0 (en) * 2002-11-08 2002-11-21 Cellestis Limited Diagnostic assay
WO2005012907A1 (en) * 2003-08-01 2005-02-10 Renovar, Inc. Systems and methods for characterizing kidney diseases
US7575862B2 (en) * 2003-12-09 2009-08-18 Asiagen Corporation Assay systems, kits and methods for detecting microorganisms
WO2005091969A2 (en) 2004-03-04 2005-10-06 Laura Manuelidis Pre-symptomatic markers for diseases associated with transmissible spongiform encephalopathies
JP2008507259A (ja) * 2004-05-24 2008-03-13 ベイラー・リサーチ・インスチチユート 免疫応答の評価方法
US7332294B2 (en) * 2004-08-17 2008-02-19 University Health Network CXCL10-based diagnosis and treatment of respiratory illnesses
CA2478138A1 (en) 2004-08-17 2006-02-17 University Health Network Cxcl10-based diagnosis and treatment of respiratory illnesses
EP1885852B1 (de) * 2005-05-05 2010-08-25 The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services Verfahren und zusammensetzungen zum nachweis von immunantworten
EP1767937A1 (de) 2005-09-27 2007-03-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verfahren zur Diagnose von tuberkulosebedingtem Immunrekonstitutionssyndrom (IRS)
WO2007106536A2 (en) * 2006-03-14 2007-09-20 Oregon Health & Science University Methods for producing an immune response to tuberculosis
CN1866023B (zh) * 2006-05-25 2010-11-03 上海市肺科医院 一种同步检测多种结核杆菌特异性分泌抗原的方法

Also Published As

Publication number Publication date
US20100086950A1 (en) 2010-04-08
BRPI0714744A8 (pt) 2016-04-05
ZA200902297B (en) 2015-10-28
DK2128612T3 (da) 2011-07-18
EP2059816A2 (de) 2009-05-20
AU2007294293B2 (en) 2013-06-27
KR101248491B1 (ko) 2013-04-03
EP2128612A3 (de) 2009-12-09
BRPI0714744B8 (pt) 2021-07-27
PT2128612E (pt) 2011-07-06
CN101523217B (zh) 2014-03-19
EP2128612B1 (de) 2011-03-30
CA2662429A1 (en) 2008-03-13
WO2008028489A3 (en) 2008-05-15
CN101523217A (zh) 2009-09-02
JP2010502200A (ja) 2010-01-28
DE602007013620D1 (de) 2011-05-12
EA020412B1 (ru) 2014-11-28
EA200970246A1 (ru) 2009-10-30
EP2228651A1 (de) 2010-09-15
US20120015386A1 (en) 2012-01-19
KR20090074026A (ko) 2009-07-03
CA2662429C (en) 2016-06-28
BRPI0714744A2 (pt) 2013-05-07
ATE504000T1 (de) 2011-04-15
WO2008028489A2 (en) 2008-03-13
EP2128612A2 (de) 2009-12-02
JP5805368B2 (ja) 2015-11-04
EP2261658A2 (de) 2010-12-15
EP2261658B1 (de) 2015-01-28
BRPI0714744B1 (pt) 2018-10-16
AU2007294293A1 (en) 2008-03-13
DK2261658T3 (en) 2015-04-27
EP2261658A3 (de) 2011-05-11
PL2128612T3 (pl) 2011-09-30
US8026076B2 (en) 2011-09-27

Similar Documents

Publication Publication Date Title
WO2008028489A3 (en) Ip-i0 based immunological monitoring
AU2002952548A0 (en) Diagnostic assay
EP1563300A4 (de) Diagnoseverfahren für sprue/zeliakie
WO2010027903A3 (en) Lung cancer diagnosis
MX374971B (es) Metodos y aparato para la deteccion de sensibilidad al gluten y su diferenciacion de la enfermedad celiaca
WO2005054853A3 (en) Method for diagnosing diseases based on levels of anti-glycan antibodies
CA2820841C (en) Competitive biosensor having elevated sensitivity
EP2527358A3 (de) Diagnostischer Assay
EP1747025A4 (de) Verfahren zur diagnose von infektionskrankheiten
WO2010108245A3 (pt) Uso de antígenos de leishmania em método diagnóstico, vacina e terapia para leishmaniose
Guaman et al. Detection of Helicobacter pylori from human biological samples (feces) by antigenic screening and culture
GB0616238D0 (en) Diagnostic Test
ES2397811T3 (es) Procedimiento para la determinación de infecciones por Trichinella
BR0318688A (pt) polipeptìdeo para o diagnóstico e terapia de leishmania
DE602007009713D1 (en) Cross-spot
WO2011153590A8 (en) Use of interferon epsilon in methods of diagnosis and treatment
PL360969A1 (en) Method for obtaining diagnostic immunological preparation and determination of advanced glycolysis level in serum and biological samples using specific imunochemical tests
UA67265A (en) Strain of bacteria campylobacter fetus subspecies fetus 5-ob serologic variant ii being used for the preparation of campilobacterial antigen and campilobacterial diagnostic serum
TR200301829U (tr) Tüberküloz tanısı için örnek işleme kiti.
RU2006110845A (ru) Способ дифференциальной диагностики бактериального лимфаденита и вирусного лимфаденита
ATE545027T1 (de) Probensammelverfahren
UA27414U (en) Method for predicting infectious complication in patients with toxico--septic biliary syndrome
GB0315512D0 (en) Diagnostic test
SG152020A1 (en) Diagnostic methods
WO2005124362A3 (de) Verfahren und testkit zur diagnose einer ischämischen herzschädigung, insbesondere der latenten chronischen formen, durch serologischen nachweis der myosin lechtkette-1